drugset / Trial / NCT00522743
Growth and Metabolic Response to GH and GnRHa Treatment Versus GH Alone in Boys Born SGA.
RandomizedParallel-groupOpen-labelTreatment
Summary
A 2-arms randomized open prospective intervention study to determine the Growth and metabolic response to growth hormone and gonadotropin-releasing hormone agonist treatment versus growth hormone alone in boys born SGA. All subjects will be treated with NorditropinSimplex at a dosage of 100mcg/kg/d. At onset of puberty, subjects will be randomized into either combined treatment with GH and GnRHa or GH alone.
Timeline
- Start
- 2005-05
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NorditropinSimplex | Protein / enzyme biologic | 100 ug/kg | — |